
Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Germany's Pistorius: NATO protects Europe from Iranian missiles - 2
The Force of Organic product: 10 Assortments That Improve Your Wellbeing - 3
Volkswagen Just Revealed a Massive Range-Extended SUV for China, and America Isn’t Getting It - 4
Picking the Right Pot for Your Plants: An Aide for Plant Devotees - 5
FDA official discusses potential link between COVID-19 vaccines and pediatric deaths
Coca-Cola Co. and bottlers to invest in South Africa operations
The most effective method to Decisively Plan Your Nursing Profession for the Best Compensation Results
Brazil Passes Law to Use Seized Bitcoin, Crypto to Fund Public Security Measures
Oldest evidence of human fire-making discovered at site in England
What is colostrum? And should you be taking it?
When a sperm whale gives birth, the mother gets help from her friends
Mother and Stepson Rescued After Being Swept Over 6 Miles in Paddleboarding Mishap
NASA Artemis II tracker: Where is the Orion now and when will it reach the moon?
Finding Europe's Head Traveler Objections: An Excursion Through Famous Attractions












